Alacris Theranostics GmbH

Alacris Theranostics GmbH is an SME in Berlin, Germany that has taken part in 11 EU-funded projects since 2011, receiving €12.7M in EU funding and leading 1 as coordinator.

EU funding received€12.7M
EU projects11
As coordinator1
Running now1
First EU project2011
Latest project2019
CountryGermany
EU registration (PIC)986091428
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Alacris Theranostics GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€6.6M · 4 projects
  • Horizon 2020€6.1M · 7 projects

Projects

11 EU-funded projects, newest first. Alacris Theranostics GmbH led 1 of them as coordinator. Each links to the official record.

  • 3TRPartner

    Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

    Horizon 2020 · 2019–2028 · Project on CORDIS ↗

    €106ktheir share
  • iPCPartner

    individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €861ktheir share
  • TAPASPartner

    TArgeting Platelet Adhesion receptors in thrombosiS

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €249ktheir share
  • CanPathProCoordinator

    Generation of the CanPath prototype - a platform for predictive cancer pathway modeling

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €3.4Mtheir share
  • PROSEQOPartner

    PROtein SEQuencing using Optical single molecule real-time detection

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €375ktheir share
  • SMARToolPartner

    Simulation Modeling of coronary ARTery disease: a tool for clinical decision support

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €811ktheir share
  • CANCER-IDPartner

    Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood

    FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗

    €240ktheir share
  • TREGenerationPartner

    Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €278ktheir share
  • SYBILPartner

    Systems biology for the functional validation of genetic determinants of skeletal diseases

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €667ktheir share
  • ITFoMPartner

    IT Future of Medicine

    FP7 (2007 to 2013) · 2011–2012 · Project on CORDIS ↗

  • ONCOTRACKPartner

    OncoTrack - Methods for systematic next generation oncology biomarker development

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €5.7Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • amines
  • arteriosclerosis
  • breast cancer
  • cardiovascular diseases
  • cell biology
  • computed tomography
  • drug discovery
  • eHealth
  • exposomes
  • genetics
  • genomes
  • graft versus host disease
  • lung cancer

Alacris Theranostics GmbH is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime